725 - Motif Bio #MTFB Tekcapital #TEK Russ Mould on #RIV #DGOC #ZYT and Simon French
Graham Lumsden, CEO of Motif Bio #MTFB talks about the list of the drug-resistant bacteria that World Health Organization has recently drawn up, and hwo their drug, Iclaprim, could possibly address some of these infections. (Interview starts at 1 minutes 36 seconds)
Dr Clifford Gross, Chairman and CEO of Tekcapital #TEK covers the news and products released by global medical device company Belluscura. Tekcapital owns approximately 65% of the share capital of Belluscura. (Interview starts at 14 minutes 35 seconds)
Russ Mould, Investment Director at stockbroker AJ Bell talks about the following stocks: River & Mercantile Group #RIV Diversified Gas & Oil #DGOC Zytronic #ZYT (Interview starts at 31 minutes 36 seconds)
Simon French Chief Economist at Panmure Gordon talks about: UK PMI's, the chances of a Fed rate hike and the big news to look out for next week. (Interview starts at 42 minutes 38 seconds)
Plus The Top 5 Most Followed Companies on Vox Markets in the Last 24 Hours and The Top 5 Most Liked RNS's on the Vox Markets website this morning. (Feature starts at 50 minutes 10 seconds)
#VoxMarkets #StockMarket #LivePrices #Money #Investing #Finance #Business
For more information on any of the companies above, please visit: http://www.voxmarkets.co.uk/blog